Sondak VK - Search Results

1

Combined BRAF and HSP90 Inhibition in Patients with Unresectable BRAF ^V600E-Mutant Melanoma.

Eroglu Z, Chen YA, Gibney GT, Weber JS, Kudchadkar RR, Khushalani NI, Markowitz J, Brohl AS, Tetteh LF, Ramadan H, Arnone G, Li J, Zhao X, Sharma R, Darville LNF, Fang B, Smalley I, Messina JL, Koomen JM, Sondak VK, Smalley KSM. Eroglu Z, et al. Among authors: sondak vk. Clin Cancer Res. 2018 Nov 15;24(22):5516-5524. doi: 10.1158/1078-0432.CCR-18-0565. Epub 2018 Apr 19. Clin Cancer Res. 2018. PMID: 29674508 Free PMC article. Clinical Trial.

2

Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.

Margolin KA, Liu PY, Unger JM, Fletcher WS, Flaherty LE, Urba WJ, Hersh EM, Hutchins LE, Sosman JA, Smith JW, Weiss GR, Sondak VK. Margolin KA, et al. Among authors: sondak vk. J Cancer Res Clin Oncol. 1999;125(5):292-6. doi: 10.1007/s004320050276. J Cancer Res Clin Oncol. 1999. PMID: 10359134 Free article. Clinical Trial.

3

Sentinel node biopsy for thin melanomas: which patients should be considered?

Puleo CA, Messina JL, Riker AI, Glass LF, Nelson C, Cruse CW, Johnson TM, Sondak VK. Puleo CA, et al. Among authors: sondak vk. Cancer Control. 2005 Oct;12(4):230-5. doi: 10.1177/107327480501200404. Cancer Control. 2005. PMID: 16258494 Free article. Review.

4

Cutaneous melanoma: methods of biopsy and definitive surgical excision.

Riker AI, Glass F, Perez I, Cruse CW, Messina J, Sondak VK. Riker AI, et al. Among authors: sondak vk. Dermatol Ther. 2005 Sep-Oct;18(5):387-93. doi: 10.1111/j.1529-8019.2005.00045.x. Dermatol Ther. 2005. PMID: 16297013 Review.

5

Allogeneic and autologous melanoma vaccines: where have we been and where are we going?

Sondak VK, Sabel MS, Mulé JJ. Sondak VK, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2337s-2341s. doi: 10.1158/1078-0432.CCR-05-2555. Clin Cancer Res. 2006. PMID: 16609055 Free article. Review.

6

Current status of biomarkers for melanoma metastasis.

Sondak VK, Messina JL. Sondak VK, et al. IDrugs. 2006 Sep;9(9):627-31. IDrugs. 2006. PMID: 16952070 Review.

7

Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.

Jensen EH, Lewis JM, McLoughlin JM, Alvarado MD, Daud A, Messina J, Enkemann S, Yeatman TJ, Sondak VK, Riker AI. Jensen EH, et al. Among authors: sondak vk. Ann Surg Oncol. 2007 Apr;14(4):1416-23. doi: 10.1245/s10434-006-9226-2. Epub 2006 Dec 30. Ann Surg Oncol. 2007. PMID: 17195911

8

Sentinel lymph node biopsy as the standard of care for cutaneous melanoma.

Sondak VK, Zager JS, Messina JL, Thomas JM. Sondak VK, et al. Clin Adv Hematol Oncol. 2007 Jun;5(6):483-90. Clin Adv Hematol Oncol. 2007. PMID: 17679922 No abstract available.

9

Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026.

Hutchins LF, Moon J, Clark JI, Thompson JA, Lange MK, Flaherty LE, Sondak VK. Hutchins LF, et al. Among authors: sondak vk. Cancer. 2007 Nov 15;110(10):2269-75. doi: 10.1002/cncr.23035. Cancer. 2007. PMID: 17932881 Free article. Clinical Trial.

10

Lymphangiogenesis: host and tumor factors in nodal metastasis.

Sondak VK, Messina JL. Sondak VK, et al. Arch Dermatol. 2008 Apr;144(4):536-7. doi: 10.1001/archderm.144.4.536. Arch Dermatol. 2008. PMID: 18427050 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters